triaziquone has been researched along with Lupus Erythematosus, Systemic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deicher, H; Fricke, R; Krull, P | 2 |
Deicher, H; Fricke, R; Kruli, P | 1 |
Cruz, A | 1 |
1 review(s) available for triaziquone and Lupus Erythematosus, Systemic
Article | Year |
---|---|
[Treatment of chronic diseases of connective tissue by cytostatic drugs].
Topics: Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Collagen Diseases; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mercaptopurine; Methotrexate; Spondylitis, Ankylosing; Thiotepa; Triaziquone | 1970 |
3 other study(ies) available for triaziquone and Lupus Erythematosus, Systemic
Article | Year |
---|---|
[Treatment of chronic connective tissue diseases with cytostatics].
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Chronic Disease; Collagen Diseases; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Prednisolone; Spondylitis, Ankylosing; Thiotepa; Triaziquone | 1970 |
[Therapy of systemic lupus erythematosus using a cytostatic agent of the ethyleneimine group].
Topics: Adolescent; Adult; Affective Symptoms; Child; Female; Humans; Leukopenia; Lupus Erythematosus, Systemic; Middle Aged; Thrombocytopenia; Triaziquone | 1972 |
[Treatment of chronic collagen diseases using cytostatics].
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Chronic Disease; Collagen Diseases; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Nitrogen Mustard Compounds; Prednisolone; Spondylitis, Ankylosing; Triaziquone | 1970 |